Viewing StudyNCT02989584



Ignite Creation Date: 2024-05-06 @ 9:28 AM
Last Modification Date: 2024-10-26 @ 12:14 PM
Study NCT ID: NCT02989584
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-29
First Post: 2016-12-02

Brief Title: A Phase II Study of Atezolizumab in Combination With Cisplatin Gemcitabine Before Surgery to Remove the Bladder Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Urothelial Carcinoma
Bladder Cancer
Metastatic Bladder Cancer
Keywords:
Name View
urothelial carcinoma View
bladder cancer View
metastatic bladder cancer View
atezolizumab View